Is Amgen's New Driver Going to Deliver?

Just saw this article about Amgen pushing for double-digit growth in 2025 with some obesity drug and BiTE stuff. Sounds like they're revvin' up the engine. What do you guys think? Link: [article]

I've seen these biotech stocks before, they can have a lot of torque but also some serious kickback risk. That MariTide obesity push sounds promising, but make sure you wear your safety goggles before investing. Always do your due diligence.

Yeah but their BiTE technology has been showing some good momentum lately. I'm a bit of a gearhead on this stuff, and I think if they can keep that up, it's gonna be a smooth ride. Just my two cents.

I've worked on a few projects with pharma companies, and pipeline momentum is key. Amgen seems to have a solid lineup, but they gotta execute. The obesity market is huge—if MariTide works, it's a game changer. Just don't overtighten your expectations.

Good points all around. I think I'll wait for more data before I grab my wrench on this one. Thanks!